ISSN:

Journal Home

Lung Cancer: Targets and Therapy Q2 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lung Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 27. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lung cancer, palliative care, cancer screening. It has an SJR impact factor of 0,979 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,979.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q2)

Price

1602 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,979

SJR Impact factor

27

H Index

12

Total Docs (Last Year)

33

Total Docs (3 years)

446

Total Refs

143

Total Cites (3 years)

31

Citable Docs (3 years)

5.32

Cites/Doc (2 years)

37.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2

Compare this journals

Aims and Scope

Lung cancer Palliative care Cancer screening